Ra Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
February 27, 2020 at 06:29 am EST
Ra Pharmaceuticals, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was USD 3.000 million compared to USD 2.500 million a year ago. Operating loss was USD 106.979 million compared to USD 66.388 million a year ago. Net loss was USD 102.688 million compared to USD 64.943 million a year ago. Basic loss per share from continuing operations was USD 2.31 compared to USD 2.06 a year ago.